Navigation Links
Gene Plays 'Jekyll-and-Hyde' Role in Deadly Brain Cancer
Date:2/7/2008

Study finds STAT3 can act as tumor suppressor, keeping bad cells in check

THURSDAY, Feb. 7 (HealthDay News) -- A gene called STAT3 acts like "Jekyll and Hyde" in glioblastoma brain cancer, according to a study led by Harvard Medical School researchers.

The finding may help improve treatment of people with the deadly disease.

Glioblastoma tends to strike people in the prime of life and is almost always fatal. There are limited treatment options, which have changed little over decades.

Previous research has shown that STAT3 is an oncogene in several types of glioblastoma. An oncogene is a gene whose normal functions are disrupted and, as a result, helps promote tumor development. In such cases, blocking STAT3 would be a way of fighting these tumors.

But this new study found that STAT3 is actually a tumor-suppressor gene in other types of glioblastoma, meaning that the gene keeps renegade cancer cells in check.

So, depending on a person's genetic makeup, STAT3 can play completely different roles in glioblastoma, the researchers said.

"This discovery lays the foundation for a more tailored therapeutic intervention. And that's really important. You can't just go blindly treating people by inhibiting STAT3," study senior author Azad Bonni, an associate professor of pathology at Harvard Medical School, said in a prepared statement.

The study was published online Feb. 6 in the journal Genes & Development.

More information

The U.S. National Cancer Institute has more about brain tumors.



-- Robert Preidt



SOURCE: Harvard Medical School, news release, Feb. 6, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Laboratory at UI plays major role in diagnosing cancer
2. Environment plays key role in childrens readiness for school
3. Gene Plays Role in Risk of Autism
4. Heart-Shaped Light Displays on Blue Cross Blue Shield of Michigan Building Show Support for American Heart Month, National Wear Red Day
5. Study Spots Gene That Plays Role in Infertility
6. One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project
7. Gene plays Jekyll and Hyde in brain cancer
8. Scientists Probe Sepsis Deadly Secrets
9. HIV denialists spread misinformation online -- consequences could be deadly; and more
10. Greeks get space-based help in wake of deadly fires
11. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2017)... ... May 29, 2017 , ... Thomas Dickerson, ... is the new president of the Board of Directors for the Radiology ... administrators. He succeeds outgoing Board President Jim Hamilton, MHA, CMM, FRBMA, an administrator ...
(Date:5/28/2017)... ... 2017 , ... HYPERAMS, LLC announced it will perform the inventory ... Lima, Ohio. The sale began this week and the inventory is expected to sell ... uniforms, and medical accessories, including blood pressure cuffs, stethoscopes, CPR masks, as well as ...
(Date:5/27/2017)... Angeles, California (PRWEB) , ... May 26, 2017 , ... ... senior citizens who visit a doctor for colds or respiratory issues that are not ... that excessive time pressure on doctors may be largely responsible for the problem both ...
(Date:5/27/2017)... (PRWEB) , ... May 27, 2017 , ... Most us ... concern, but a new study from the Osteoarthritis Initiative shows that certain ... knee osteoarthritis. Knowing this in advance may give doctors the opportunity to treat patients ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... to announce a new educational seminar to focus on current legislative activity and ... seminar will begin at 1 p.m. Sunday, Sept. 10, and will continue through ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... , May 10, 2017 Radiology has become ... its costs have also spiraled to the number one ... to radiology than ever before as the most complete ... a patient with lower back pain an MRI may ... reason for pain, resulting in entirely different treatment protocols.  ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/6/2017)... 2017   Provista , a proven leader in the ... today announced Jim Cunniff as the company,s new ... business experience to Provista, including most recently serving as the ... California . He assumed his new role with Provista ... fit for Provista," says Jody Hatcher , president, Sourcing ...
Breaking Medicine Technology: